United Kingdom Archives

centauri therapeutics fundraising alphamer anti infective e1487589778369

News and Trends 20 Feb 2017

Alphamer Technology gets Seed Fundraising to Fight Antibiotic Resistance

Centauri Therapeutics has raised £1.2M in the second part of its seed round, which will be directed at bringing its first alphamer to the preclinical stage. Centauri Therapeutics, a young British biotech, is developing alphamer technology to fights infectious disease and cancer. Today, the company has announced the addition of £1.2M from existing and new investors […]

February 20, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Russ Cummings Touchstone Innovations Edited e1487839162471

Interview 20 Feb 2017

Investment CEO shares Tips for Academics on Succeeding in Business

With decades of experience, the CEO of Touchstone Innovations tells us about funding the development of academic projects into commercialized products Formerly known as Imperial Innovations, the investing arm of Imperial College in London has since morphed into Touchstone Innovations, an UK technology commercialization and investment company with the same core mission in bridging the gap […]

February 20, 2017 - 7 minutesmins - By Evelyn Warner

Sarah Craske biological hermeneutics e1487347991799

News and Trends 18 Feb 2017

Microorganisms in the Library: Bringing Centuries-Old Books to Life

Sarah Craske describes herself as a “British artist, without category.” Her work, at the intersection of art and science, revolves around the development of her own discipline: Biological Hermeneutics. Hermeneutics refers to the interpretation of texts, a term commonly used regarding the bible or philosophy. Craske translates the concept to biology by exploring the role […]

February 18, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 17 Feb 2017

UPDATE: British Biotech Investment Company goes Public with €117M

UPDATE (17/02/2017): Arix Bioscience announced that it has successfully raised £100M (€117) in an oversubscribed IPO on the London Stock Exchange. Originally published on 02/02/2017 Arix Bioscience is getting ready for an IPO that could reach up to €117M (£100M). The funds will be directed at small life science companies. Arix Bioscience is a ‘global healthcare and life […]

February 17, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Antibiotic Resistance Queens University Belfast

News and Trends 16 Feb 2017

British Scientists Discover how Deadly Bacteria Survive a Last-Line Antibiotic

Researchers from the UK and Australia have described for the first time the detailed molecular mechanisms behind last-line antibiotic resistance. A month ago, the news of a woman who died of an infection with a bacteria resistant to all 26 antibiotics available in the US traveled the world. The bacterial strain responsible, Klebsiella pneumoniae, is one […]

February 16, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 16 Feb 2017

The Patent Office has Spoken: What does it Mean for CRISPR in Europe?

The US Patent Office has ruled that the Broad Institute’s CRISPR patents do not interfere with those from UC Berkeley. While this might sound like everybody wins, it’s actually a loss for Charpentier and the CRISPR Therapeutics team. CRISPR has been hailed as the ‘scientific discovery of the century’. This molecular technique could be used […]

February 16, 2017 - 4 minutesmins - By Clara Rodríguez Fernández

News and Trends 14 Feb 2017

Dual HIV Therapy: GSK and Gilead Battle over Whose Drug is the Best

GSK announced Phase III results for dolutegravir, which could reduce triple HIV therapy down to two drugs, but Gilead is trying to prove that its candidate bictegravir is better. GSK and Gilead have announced they will present detailed data backing their candidates for a dual HIV therapy. The battlefield will be the Annual Conference on Retroviruses […]

February 14, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 13 Feb 2017

Biotech from the Bermuda Islands Brings Good News for Dementia Patients

Axovant Sciences has announced positive preliminary results from a Phase II trial directed at reducing hallucinations in patients with dementia. Axovant Sciences is a biotech located in Bermuda, a British tropical island in the Atlantic ocean. From there, the company develops drugs against dementia. The company was founded by young biotech entrepreneur Vivek Ramaswamy, which has […]

February 13, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Acacia Pharma Phase III Post Operative Nausea

More News! 13 Feb 2017

To the Rescue: A Final Phase III Success for Post-Operative Nausea

The dopamine antagonist Baremsis is on its way to FDA approval for the treatment and prophylaxis of post-operative nausea & vomiting, after succeeding in a final phase III study. Acacia Pharma, one of our Cambridge top 15 biotechs, is repurposing marketed drugs to provide supportive treatments for post-surgical or cancer patients. Their lead project, Baremsis, is a dopamine antagonist, which Acacia is […]

February 13, 2017 - 3 minutesmins - By Melanie De Almeida

More News! 11 Feb 2017

This Musician Plays Piano Duets with a Microorganism

Eduardo Miranda researches, composes and performs contemporary music at the interface of biology, computing and the human mind. Eduardo Miranda, Professor of Computer Music at Plymouth University, is the first person to ever compose and perform a piano piece for a human and a microorganism. To allow the tiny creature to play with him, Miranda […]

February 11, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

More News! 9 Feb 2017

After its First Success, the Virtual Biotech Team is Back at it Again

SuperX has raised €10.3M ($11M) in Series A from Medicxi and J&J Innovation to develop anticoagulant antibodies for stroke and heart attacks. The team behind XO1, which was acquired by J&J’s Janssen back in 2015, is repeating the whole process again. Their new company, SuperX, is also focused on the discovery of anticoagulant antibodies to treat […]

February 9, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

gw pharmaceuticals brain tumor cannabinoid

News and Trends 7 Feb 2017

Cannabinoid Drug Prolongs the Life of Brain Tumor Patients in Phase II Trials

GW Pharmaceuticals announced Phase II results for a cannabinoid drug combination with the potential to increase life expectancy in patients with an aggressive form of brain cancer. GW Pharmaceuticals, one of the coolest biotechs in Cambridge, is developing cannabinoid drugs. Its lead candidate, Epidiolex, could reach the market soon and help treat drug-resistant forms of […]

February 7, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

United Kingdom

Alphamer Technology gets Seed Fundraising to Fight Antibiotic Resistance

Investment CEO shares Tips for Academics on Succeeding in Business

Microorganisms in the Library: Bringing Centuries-Old Books to Life

UPDATE: British Biotech Investment Company goes Public with €117M

British Scientists Discover how Deadly Bacteria Survive a Last-Line Antibiotic

The Patent Office has Spoken: What does it Mean for CRISPR in Europe?

Dual HIV Therapy: GSK and Gilead Battle over Whose Drug is the Best

Biotech from the Bermuda Islands Brings Good News for Dementia Patients

To the Rescue: A Final Phase III Success for Post-Operative Nausea

This Musician Plays Piano Duets with a Microorganism

After its First Success, the Virtual Biotech Team is Back at it Again

Cannabinoid Drug Prolongs the Life of Brain Tumor Patients in Phase II Trials

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!